Semaglutide is a long-acting GLP-1 receptor agonist peptide used in diabetes and obesity research. It enhances insulin secretion, suppresses appetite, and improves glycemic control.
Application: Metabolic disease research, obesity and diabetes modeling, preclinical drug candidate evaluation, neuroendocrine function studies